34 related articles for article (PubMed ID: 11057321)
21. [Reduction of adverse reactions of anticancer agents with altered dose and schedule].
Horikoshi N
Nihon Rinsho; 2003 Jun; 61(6):1021-4. PubMed ID: 12806954
[TBL] [Abstract][Full Text] [Related]
22. Dexamethasone premedication for prophylaxis of taxane toxicities: can the doses be reduced when paclitaxel or docetaxel are given weekly?
Schwartz JR
J Oncol Pharm Pract; 2012 Jun; 18(2):250-6. PubMed ID: 21807762
[TBL] [Abstract][Full Text] [Related]
23. Prophylaxis for paclitaxel hypersensitivity reactions.
Kintzel PE
Ann Pharmacother; 2001 Sep; 35(9):1114-7. PubMed ID: 11573863
[TBL] [Abstract][Full Text] [Related]
24. Secondary breast angiosarcoma and paclitaxel-dependent prolonged disease control: report of two cases and review of the literature.
Gambini D; Visintin R; Locatelli E; Bareggi C; Galassi B; Runza L; Blundo C; Sosnovskikh I; Tomirotti M
Tumori; 2015 Apr; 101(2):e60-3. PubMed ID: 25744864
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticle albumin-bound paclitaxel for treatment of metastatic breast cancer.
Pinder MC; Ibrahim NK
Drugs Today (Barc); 2006 Sep; 42(9):599-604. PubMed ID: 17028669
[TBL] [Abstract][Full Text] [Related]
26. Theoretical and practical aspects of paclitaxel scheduling.
Gianni L
Ann Oncol; 1995 Nov; 6(9):861-3. PubMed ID: 8624286
[No Abstract] [Full Text] [Related]
27. [Weekly administration of paclitaxel for advanced or metastatic breast cancer--short-course premedications for outpatients].
Kimura M; Koida T; Yanagita Y
Gan To Kagaku Ryoho; 2000 Oct; 27(11):1703-8. PubMed ID: 11057321
[TBL] [Abstract][Full Text] [Related]
28. [Weekly administration of paclitaxel with a short course of premedication for advanced or recurrent gastric cancer].
Yamamoto S; Tanaka Y; Ito T; Nakai S; Morimoto Y; Kitagawa T; Kurihara Y; Nishimura J
Gan To Kagaku Ryoho; 2003 Jan; 30(1):67-71. PubMed ID: 12557707
[TBL] [Abstract][Full Text] [Related]
29. Single-agent paclitaxel for the treatment of breast cancer: an overview.
Hortobagyi GN; Holmes FA
Semin Oncol; 1996 Feb; 23(1 Suppl 1):4-9. PubMed ID: 8629036
[TBL] [Abstract][Full Text] [Related]
30. Dose-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer.
Seidman AD; Hudis CA; Albanell J; Tong W; Tepler I; Currie V; Moynahan ME; Theodoulou M; Gollub M; Baselga J; Norton L
J Clin Oncol; 1998 Oct; 16(10):3353-61. PubMed ID: 9779712
[TBL] [Abstract][Full Text] [Related]
31. Weekly paclitaxel in the management of ovarian cancer.
Markman M
Semin Oncol; 2000 Jun; 27(3 Suppl 7):37-40. PubMed ID: 10952125
[TBL] [Abstract][Full Text] [Related]
32. Taxol: initial Israeli experience with a novel anticancer agent.
Sulkes A; Beller U; Peretz T; Shacter J; Hornreich G; McDaniel C; Winograd B
Isr J Med Sci; 1994 Jan; 30(1):70-8. PubMed ID: 7908013
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
